Prognostic Nomogram For Patients With BRCA Mutation Positive Platinum-sensitive Recurrent Ovarian Cancer
A tool for health care professionals and researchers to prognosticate progression-free survival outcomes in patients with BRCA mutation positive platinum-sensitive recurrent ovarian cancer about to commence with maintenance olaparib therap
Disclaimer & Privacy
The NHMRC Clinical Trials Centre (CTC) strives to keep information stored in this tool up to date, but does not guarantee the accuracy, reliability or currency of the information. Any errors in the information that are brought to our attention will be corrected as soon as possible. The CTC reserves the right to change at any time without notice any information stored in this tool